Window-of-Opportunity Trial of Ulixertinib for MAPK-Activated Gliomas
This study is testing an experimental cancer drug called ulixertinib to see if it can successfully reach brain tumors. Researchers want to find out if the medicine can cross the protective barrier around the brain to help patients with specific types of brain or nerve tumors.
You may be able to join if you are at least 18 years old for surgery cases (or at least 12 for non-surgery cases) and have a brain or nerve tumor with certain genetic changes. You also need to meet specific health and body size requirements and not be on certain recent treatments.
Participants will take the study drug, ulixertinib, and have their health closely monitored by the medical team. Your doctors will check how your body responds to the treatment and whether the medicine is reaching the tumor.
This study is currently recruiting participants in Houston, Texas, United States. You can talk to your care team to see if traveling to this location is an option for you.
- 1Testing an experimental drug called ulixertinib for brain tumors
- 2Checking if the medicine can cross the blood-brain barrier
- 3Currently recruiting patients in Houston, Texas
No related links yet
Seen this study covered in the news, or found a page that explains it well? Send it over and we'll review it.
Suggest a linkThis summary was generated using AI and may not capture all details. Always consult with a healthcare professional for medical advice.